Frequency of HBV, HCV and HIV Infections and Determination of HCV Genotype Distribution in People who Inject Drugs
Journal Title: Viral Hepatitis Journal - Year 2021, Vol 27, Issue 1
Abstract
Objectives: The aim of this study was to determine the frequency of blood-borne infections [hepatitis B virus (HBV), HCV, and human immunodeficiency virus (HIV)] and the genotype distribution retrospectively in people who inject drugs (PWID). Materials and Methods: A total of 150 PWID were investigated retrospectively. HBV, HCV, HIV serologies and viral load information were recorded. Results: The mean age was 27.0±4.89 and 13 (8.7%) patients were female. One hundred and twenty six (84.0%) patients had shared injectors at least once in their lives. Anti-HCV positivity was detected in 91 (60.6%) of 150 patients, hepatitis B surface antigen positivity in 3 (2.0%) and anti-HIV positivity in 1 patient. HCV-RNA was detected in 61 of the patients with anti-HCV positivity and 48 (67.6%) of them were positive for HCV-RNA. Genotype was studied in 38 patients with HCV-RNA positivity. Genotype 1a was detected in 20 patients, genotype 3a in 12 patients, genotype 4c/d in 5 patients and 2b in 1 patient. Conclusion: In PWID, HCV infection was found to be in high ratio in PWIDs and the most common HCV genotype was 1a. It was concluded that injector sharing caused infectious diseases in PWID and that some HCV genotypes were dominant in these patients. Genotype determination will be a guide for individualized treatments in these patients.
Authors and Affiliations
Hüseyin Kara, Dilara İnan, Özgen Özçelik, Ali Erdoğan, Dilek Çolak, Gözde Öngüt
Keywords
Related Articles
- EP ID EP694435
- DOI 10.4274/vhd.galenos.2021.2020-12-6
- Views 79
- Downloads 0
Relationship Between Basic Laboratory Results and Fibrosis in Chronic Hepatitis B Patients
Objectives: Liver biopsy (LB) is an important cornerstone in decision to start treatment for chronic hepatitis B (HB). Viral load and liver function tests are performed to determine the most appropriate time. In this stu...
Non-hodgkin Lymphoma Developing After Discontinuation of Direct-acting Antiviral Treatment for Hepatitis C: A Case Report
Today, direct-acting antivirals (DAA) are the main treatment options for hepatitis C infection. However, whether malignancy risk is increased after DAA treatment is a matter of debate. Conflicting results have been repor...
Influence of Sustained Virological Response on APRI in Chronic Hepatitis C: is APRI a Marker of Only the Stage of Fibrosis?
Objectives: Aspartate transaminase (AST) to platelet ratio index (APRI) is widely used to predict the stage of liver fibrosis in patients with chronic hepatit C virus (HCV) infection. In this study, we aimed to evaluate...
Intravenous Drug Use Rates and Results of Direct-acting Antiviral Treatment in Prisoner Patients
Objectives: Intravenous drug use (IVDU) is more common in prisoner patients, and this is a global problem. Hepatitis C virus (HCV) infection is higher in prisoners than general population. In our study, we aimed to exami...
Hepatitis C Virus Genotype Distribution in Forensic Cases
Objectives: In this study, we aimed to determine the hepatitis C virus (HCV) genotype and subtypes in blood samples that were determined by polymerase chain reaction (PCR) in autopsy cases. Materials and Methods: The bl...